Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026)
Sarepta Therapeutics' (SRPT) quarterly FCF Margin came in at 28.02% in Q1 2026, up 44230.0% year-on-year from N/an in Q1 2025, and down 197.25% quarter-over-quarter from 28.81% in Q4 2025.
Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' FCF Margin history runs 15 years deep, the most recent figure standing at 28.02% for Q1 2026.
- On a quarterly basis, FCF Margin rose 44230.0% year-over-year to 28.02% in Q1 2026; TTM through Mar 2026 was 5.26%, a 4813.0% increase from a year earlier, with the FY2025 full-year figure at 16.49%, up 153.0% from the prior year.
- FCF Margin declined to 28.02% in Q1 2026 per SRPT's latest filing, from 28.81% in the prior quarter.
- Across five years, FCF Margin topped out at 37.56% in Q2 2025 and bottomed at 470.32% in Q1 2025.
- The 5-year median for FCF Margin is 28.02% (2026), against an average of 50.83%.
- Across the five-year window, FCF Margin jumped 56199 bps in 2022 and tumbled 40392 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 11.58% in 2022, then surged by 41 bps to 6.84% in 2023, then jumped by 220 bps to 8.2% in 2024, then surged by 252 bps to 28.81% in 2025, then sank by 197 bps to 28.02% in 2026.
- Per Business Quant, the three latest SRPT FCF Margin figures stand at 28.02% (Q1 2026), 28.81% (Q4 2025), and 9.39% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | -28.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.02% |
| Dec 31, 2025 | 28.81% |
| Sep 30, 2025 | -9.39% |
| Jun 30, 2025 | 37.56% |
| Mar 31, 2025 | -470.32% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | -23.11% |
| Jun 30, 2024 | -3.92% |
| Mar 31, 2024 | -66.40% |
| Dec 31, 2023 | -6.84% |
| Sep 30, 2023 | -46.68% |
| Jun 30, 2023 | -53.65% |
| Mar 31, 2023 | -94.55% |
| Dec 31, 2022 | -11.58% |
| Sep 30, 2022 | -31.79% |
| Jun 30, 2022 | -35.93% |
| Mar 31, 2022 | -56.53% |
| Dec 31, 2021 | -17.64% |
| Sep 30, 2021 | -593.78% |
| Jun 30, 2021 | -70.11% |